Respiratory Morbidity in Prematurely Born Children Receiving Palivizumab Prophylaxis of Respiratory Syncytial Virus Disease

Background: Preterm delivery is a risk factor for increased respiratory morbidity in early childhood. This study aimed to quantify respiratory morbidity in preterm survivors, comparing incidence rates among different gestational ages, birth weighst, and current age groups. Additionally, we sought to...

Full description

Bibliographic Details

Published in:	Iranian Journal of Neonatology
Main Authors:	Milena Bjelica, Gordana Vilotijević Dautović, Slobodan Spasojević, Marija Đermanović, Milica Plazačić
Format:	Article
Language:	English
Published:	Mashhad University of Medical Sciences 2024-04-01
Subjects:	bronchopulmonary dysplasia palivizumab premature birth respiratory infections wheezing
Online Access:	https://ijn.mums.ac.ir/article_24064_68c1e761d559784d0c4fd04829380666.pdf